1. Cancer and the tumor microenvironment: a review of an essential relationship

   • Flaubert Mbeunkui
   • Donald J. Johann Jr

   Review 14 December 2008 Pages: 571 - 582

   

2. Thalidomide-induced severe hepatotoxicity

   • Vrushali Dabak
   • Philip Kuriakose

   Review 16 December 2008 Pages: 583 - 585

   

3. Targeting MET transcription as a therapeutic strategy in multiple myeloma

   • Cornel J. Phillip
   • Christine M. Stellrecht
   • Varsha Gandhi

   Original Article 29 May 2008 Pages: 587 - 597

   

4. Renal dysfunction during and after high-dose methotrexate

   • Myke R. Green
   • Marc C. Chamberlain

   Original Article 27 May 2008 Pages: 599 - 604

5. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression

   • Yinhong Song
   • Changju Zhang

   Original Article 03 June 2008 Pages: 605 - 613

   

6. Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice

   • Jianxia Guo
   • Robert A. Parise
   • Julie L. Eiseman

   Original Article 29 May 2008 Pages: 615 - 625

   

7. Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?

   • Byeong-Bae Park
   • Ji Eun Uhm
   • Young-Hyuck Im

   Original Article 14 June 2008 Pages: 627 - 633

   

8. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B

   • Meixia Zhang
   • Hongliang Zhang
   • Yihui Deng

   Original Article 03 June 2008 Pages: 635 - 642

   

9. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na⁺,K⁺-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B

   • Zunaid Ahmed
   • Yoshiaki Deyama
   • Kuniaki Suzuki

   Original Article 11 June 2008 Pages: 643 - 650

   

10. Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition

    • Helen L. Eley
    • Pria S. McDonald
    • Michael J. Tisdale

    Original Article 14 June 2008 Pages: 651 - 659

    

11. ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair

    • Britta Stordal
    • Ross Davey

    Original Article 25 June 2008 Pages: 661 - 672

    

12. Inhibition of NF-κB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate

    • Guoyi Ma
    • Nurhayat Tabanca
    • Shabana I. Khan

    Original Article 03 July 2008 Pages: 673 - 680

    

13. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells

    • Zhenfeng Duan
    • Rachel Y. Ames
    • Michael V. Seiden

    Original Article 28 June 2008 Pages: 681 - 689

    

14. Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil

    • Sofia B. Gustafsson
    • Theres Lindgren
    • Stig O. P. Jacobsson

    Original Article 16 July 2008 Pages: 691 - 701

    

15. Phase 0 clinical trials in oncology: a paradigm shift for early drug development?

    • Chris H. Takimoto

    Original Article 10 July 2008 Pages: 703 - 709

    

16. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells

    • Sunita Yadav
    • Lilian E. van Vlerken
    • Mansoor M. Amiji

    Original Article 11 July 2008 Pages: 711 - 722

    

17. Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer

    • Dawn P. G. Brown
    • Helen Chin-Sinex
    • Mu Wang

    Original Article 12 July 2008 Pages: 723 - 730

    

18. Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy

    • Markos Leggas
    • Kuei-Ling Kuo
    • John Rinehart

    Clinical Trial Report 24 May 2008 Pages: 731 - 743

    

19. Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report

    • Celalettin Camci
    • Alper Sevinc
    • Suleyman Buyukberber

    Short Communication 27 May 2008 Pages: 745 - 748

20. Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma

    • S. V. Picton
    • J. Keeble
    • G. J. Veal

    Short Communication 08 July 2008 Pages: 749 - 752

    

21. BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line

    • Manny D. Bacolod
    • Randy Fehdrau
    • Henry S. Friedman

    Short Communication 17 July 2008 Pages: 753 - 758

    

22. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis

    • Pasquale Niscola
    • Roberto Palumbo
    • Paolo de Fabritiis

    Letter to the Editor 24 May 2008 Pages: 759 - 760